Promoted Content

Promoted Content

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Pipelines for Dental and Oral Health

All Data

Filters

refresh

×

FILTER DATA :

Study Phase

Country

News Type

Company

Product Type

refresh

Product Type

Development Status

Locust Walk

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Post An Enquiry

CPhI North America Online

Participation Not Confirmed

Update your events

Innovation Pharmaceuticals Further Engages Locust Walk to Lead Out-Licensing Negotiations for Rights to Phase 3-Ready Oral Mucositis Drug Ca...

Contact the Supplier

Lead Product(s): Brilacidin

Therapeutic Area: Dental and Oral Health Product Name: Undisclosed

Highest Development Status: Phase III Product Type: Small molecule

Partner/Sponsor/Collaborator: Innovation Pharmaceuticals

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 29, 2020

Details:

This renewed engagement is a continuation of Innovation Pharmaceutical’s business relationship with Locust Walk toward realizing the market potential of the Company’s pipeline.